Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AGNT, Inc.EXPI · Entity 5272 | Chief Legal Counsel | November 13, 2024 | November 13, 2024 |
| USANA HEALTH SCIENCES INCUSNA · Entity 6114 | Chief Legal Officer and Sec | February 05, 2018 | February 07, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AGNT, Inc.
Report date November 13, 2024 · Filed November 13, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2024-11-13 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2024-11-13 · Exercise / conversion · Acquired 25,000 · Balance 25,000 Row 2 · 2024-11-13 · Sale · Disposed 25,000 · Balance 0 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.82 to $14.3344, inclusive. The reporting person undertakes to provide to eXp World Holdings, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.32 · Expires 2029-03-18 | Direct | 38,000 |
Reported balance
After 2024-11-13 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-11-13 · Exercise / conversion · Disposed 25,000 · Balance 38,000 F2: This Stock Option vested in 16 equal quarterly installments beginning on March 18, 2019 and was fully vested on March 18, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.82 to $14.3344, inclusive. The reporting person undertakes to provide to eXp World Holdings, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F2: This Stock Option vested in 16 equal quarterly installments beginning on March 18, 2019 and was fully vested on March 18, 2023.
USANA HEALTH SCIENCES INC
Report date February 05, 2018 · Filed February 07, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 8,129 |
Reported balance
After 2018-02-05 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-02-05 · Grant · Acquired 5,580 · Balance 8,129 F1: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2: Restricted Stock Units vest 25% on the anniversary of February 5th, 2018. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
F2: Restricted Stock Units vest 25% on the anniversary of February 5th, 2018.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 13, 2024 Filed Nov 13, 2024 23:19 UTC | AGNT, Inc. EXPI · Entity 5272 | Exercise / conversionStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $5.32 | $0.00 |
DisclosureSEC source: 0001562180-24-007678 · primarydocument.xml · derivative · entry 3 Bramble James · CIK 0001441438 · Chief Legal Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,000 Underlying: Common Stock · 25,000 shares Expires 2029-03-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This Stock Option vested in 16 equal quarterly installments beginning on March 18, 2019 and was fully vested on March 18, 2023. Read SEC document |
| November 13, 2024 Filed Nov 13, 2024 23:19 UTC | AGNT, Inc. EXPI · Entity 5272 | SaleCommon Stock | 25,000 | $14.05 | $351,352.50 |
DisclosureSEC source: 0001562180-24-007678 · primarydocument.xml · nonDerivative · entry 2 Bramble James · CIK 0001441438 · Chief Legal Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.82 to $14.3344, inclusive. The reporting person undertakes to provide to eXp World Holdings, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 13, 2024 Filed Nov 13, 2024 23:19 UTC | AGNT, Inc. EXPI · Entity 5272 | Exercise / conversionCommon Stock | 25,000 | $5.32 | $133,000.00 |
DisclosureSEC source: 0001562180-24-007678 · primarydocument.xml · nonDerivative · entry 1 Bramble James · CIK 0001441438 · Chief Legal Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 08, 2023 Filed Aug 9, 2023 19:38 UTC | AGNT, Inc. EXPI · Entity 5272 | Exercise / conversionStock Option (Right to Buy) · Derivative | 38,000 | $0.00 Strike: $5.32 | $0.00 |
DisclosureSEC source: 0001562180-23-006250 · primarydocument.xml · derivative · entry 3 Bramble James · CIK 0001441438 · Chief Legal Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,000 Underlying: Common Stock · 38,000 shares Expires 2029-03-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This Stock Option vested in 16 equal quarterly installments beginning on March 18, 2019 and was fully vested on March 18, 2023. Read SEC document |
| August 08, 2023 Filed Aug 9, 2023 19:38 UTC | AGNT, Inc. EXPI · Entity 5272 | SaleCommon Stock | 38,000 | $24.54 | $932,360.40 |
DisclosureSEC source: 0001562180-23-006250 · primarydocument.xml · nonDerivative · entry 2 Bramble James · CIK 0001441438 · Chief Legal Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.24 to $24.69, inclusive. The reporting person undertakes to provide to EXP World Holdings, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| August 08, 2023 Filed Aug 9, 2023 19:38 UTC | AGNT, Inc. EXPI · Entity 5272 | Exercise / conversionCommon Stock | 38,000 | $5.32 | $202,160.00 |
DisclosureSEC source: 0001562180-23-006250 · primarydocument.xml · nonDerivative · entry 1 Bramble James · CIK 0001441438 · Chief Legal Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2023 Filed May 22, 2023 21:44 UTC | AGNT, Inc. EXPI · Entity 5272 | GrantStock Options (Right to buy) · Derivative | 150,000 | $0.00 Strike: $14.46 | $0.00 |
DisclosureSEC source: 0001562180-23-004391 · primarydocument.xml · derivative · entry 1 Bramble James · CIK 0001441438 · Chief Legal Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2033-05-19 F1 · derivative.exercise_date: The Stock Option shares vest ratably over a four-year period in 16 quarterly installments, with the final vesting date on May 19, 2027. Read SEC document |
| March 28, 2023 Filed Mar 29, 2023 20:00 UTC | AGNT, Inc. EXPI · Entity 5272 | Exercise / conversionStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $5.32 | $0.00 |
DisclosureSEC source: 0001562180-23-003165 · primarydocument.xml · derivative · entry 3 Bramble James · CIK 0001441438 · Chief Legal Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,000 Underlying: Common Stock · 30,000 shares Expires 2029-03-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This Stock Option vested in 16 equal quarterly installments beginning on March 18, 2019 and was fully vested on March 18, 2023. Read SEC document |
| March 28, 2023 Filed Mar 29, 2023 20:00 UTC | AGNT, Inc. EXPI · Entity 5272 | SaleCommon Stock | 30,000 | $11.70 | $350,925.00 |
DisclosureSEC source: 0001562180-23-003165 · primarydocument.xml · nonDerivative · entry 2 Bramble James · CIK 0001441438 · Chief Legal Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.67 to $11.74, inclusive. The reporting person undertakes to provide to EXP World Holdings, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| March 28, 2023 Filed Mar 29, 2023 20:00 UTC | AGNT, Inc. EXPI · Entity 5272 | Exercise / conversionCommon Stock | 30,000 | $5.32 | $159,600.00 |
DisclosureSEC source: 0001562180-23-003165 · primarydocument.xml · nonDerivative · entry 1 Bramble James · CIK 0001441438 · Chief Legal Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2022 Filed Aug 17, 2022 14:46 UTC | AGNT, Inc. EXPI · Entity 5272 | Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $5.32 | $0.00 |
DisclosureSEC source: 0001562180-22-006129 · primarydocument.xml · derivative · entry 3 Bramble James · CIK 0001441438 · Chief Legal Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,000 Underlying: Common Stock · 15,000 shares Expires 2029-03-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This Stock Option vests in 16 equal quarterly installments beginning on March 18, 2019. Read SEC document |
| August 16, 2022 Filed Aug 17, 2022 14:46 UTC | AGNT, Inc. EXPI · Entity 5272 | SaleCommon Stock | 15,000 | $17.04 | $255,648.00 |
DisclosureSEC source: 0001562180-22-006129 · primarydocument.xml · nonDerivative · entry 2 Bramble James · CIK 0001441438 · Chief Legal Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.00 to $17.15, inclusive. The reporting person undertakes to provide to EXP World Holdings, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| August 16, 2022 Filed Aug 17, 2022 14:46 UTC | AGNT, Inc. EXPI · Entity 5272 | Exercise / conversionCommon Stock | 15,000 | $5.32 | $79,800.00 |
DisclosureSEC source: 0001562180-22-006129 · primarydocument.xml · nonDerivative · entry 1 Bramble James · CIK 0001441438 · Chief Legal Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2022 Filed Feb 11, 2022 21:32 UTC | AGNT, Inc. EXPI · Entity 5272 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $5.32 | $0.00 |
DisclosureSEC source: 0001562180-22-001407 · primarydocument.xml · derivative · entry 3 Bramble James · CIK 0001441438 · Chief Legal Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,000 Underlying: Common Stock · 2,000 shares Expires 2029-03-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This Stock Option vests in 16 equal quarterly installments beginning on March 18, 2019. Read SEC document |
| February 10, 2022 Filed Feb 11, 2022 21:32 UTC | AGNT, Inc. EXPI · Entity 5272 | SaleCommon Stock | 2,000 | $30.00 | $60,000.00 |
DisclosureSEC source: 0001562180-22-001407 · primarydocument.xml · nonDerivative · entry 2 Bramble James · CIK 0001441438 · Chief Legal Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sale reported in this Form 4 was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| February 10, 2022 Filed Feb 11, 2022 21:32 UTC | AGNT, Inc. EXPI · Entity 5272 | Exercise / conversionCommon Stock | 2,000 | $5.32 | $10,640.00 |
DisclosureSEC source: 0001562180-22-001407 · primarydocument.xml · nonDerivative · entry 1 Bramble James · CIK 0001441438 · Chief Legal Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2022 Filed Jan 6, 2022 21:36 UTC | AGNT, Inc. EXPI · Entity 5272 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $5.32 | $0.00 |
DisclosureSEC source: 0001562180-22-000316 · primarydocument.xml · derivative · entry 3 Bramble James · CIK 0001441438 · Chief Legal Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,000 Underlying: Common Stock · 2,000 shares Expires 2029-03-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This Stock Option vests in 16 equal quarterly installments beginning on March 18, 2019. Read SEC document |
| January 04, 2022 Filed Jan 6, 2022 21:36 UTC | AGNT, Inc. EXPI · Entity 5272 | SaleCommon Stock | 2,000 | $33.65 | $67,300.00 |
DisclosureSEC source: 0001562180-22-000316 · primarydocument.xml · nonDerivative · entry 2 Bramble James · CIK 0001441438 · Chief Legal Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sale reported in this Form 4 was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 04, 2022 Filed Jan 6, 2022 21:36 UTC | AGNT, Inc. EXPI · Entity 5272 | Exercise / conversionCommon Stock | 2,000 | $5.32 | $10,640.00 |
DisclosureSEC source: 0001562180-22-000316 · primarydocument.xml · nonDerivative · entry 1 Bramble James · CIK 0001441438 · Chief Legal Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 07, 2021 Filed Dec 9, 2021 23:30 UTC | AGNT, Inc. EXPI · Entity 5272 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $5.32 Strike: $5.32 | $53,200.00 |
DisclosureSEC source: 0001562180-21-007615 · primarydocument.xml · derivative · entry 3 Bramble James · CIK 0001441438 · Chief Legal Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 10,000 shares Expires 2029-03-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Stock amounts have been adjusted for the impact of the two-for-one stock split in the form of a stock dividend paid on February 12, 2021 F4 · derivative.exercise_date: This Stock Option vests in 16 equal quarterly installments beginning on March 18, 2019. Read SEC document |
| December 07, 2021 Filed Dec 9, 2021 23:30 UTC | AGNT, Inc. EXPI · Entity 5272 | SaleCommon Stock | 10,000 | $36.87 | $368,719.00 |
DisclosureSEC source: 0001562180-21-007615 · primarydocument.xml · nonDerivative · entry 2 Bramble James · CIK 0001441438 · Chief Legal Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sale reported in this Form 4 was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.61 to $37.045, inclusive. The reporting person undertakes to provide to EXP World Holdings, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 07, 2021 Filed Dec 9, 2021 23:30 UTC | AGNT, Inc. EXPI · Entity 5272 | Exercise / conversionCommon Stock | 10,000 | $5.32 | $53,200.00 |
DisclosureSEC source: 0001562180-21-007615 · primarydocument.xml · nonDerivative · entry 1 Bramble James · CIK 0001441438 · Chief Legal Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 22, 2020 Filed Dec 24, 2020 02:11 UTC | AGNT, Inc. EXPI · Entity 5272 | Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $10.64 | $0.00 |
DisclosureSEC source: 0001562180-20-007459 · primarydocument.xml · derivative · entry 5 Bramble James · CIK 0001441438 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 20,000 shares Expires 2029-03-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This Stock Option vests in 16 equal quarterly installments beginning on March 18, 2019. Read SEC document |
| December 22, 2020 Filed Dec 24, 2020 02:11 UTC | AGNT, Inc. EXPI · Entity 5272 | SaleCommon Stock | 1,200 | $82.34 | $98,807.40 |
DisclosureSEC source: 0001562180-20-007459 · primarydocument.xml · nonDerivative · entry 4 Bramble James · CIK 0001441438 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.30 to $82.44, inclusive. The reporting person undertakes to provide to EXP World Holdings, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and ommission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| December 22, 2020 Filed Dec 24, 2020 02:11 UTC | AGNT, Inc. EXPI · Entity 5272 | SaleCommon Stock | 9,745 | $81.99 | $799,024.71 |
DisclosureSEC source: 0001562180-20-007459 · primarydocument.xml · nonDerivative · entry 3 Bramble James · CIK 0001441438 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,200 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.29 to $82.28, inclusive. The reporting person undertakes to provide to EXP World Holdings, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and ommission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| December 22, 2020 Filed Dec 24, 2020 02:11 UTC | AGNT, Inc. EXPI · Entity 5272 | SaleCommon Stock | 9,055 | $80.75 | $731,207.55 |
DisclosureSEC source: 0001562180-20-007459 · primarydocument.xml · nonDerivative · entry 2 Bramble James · CIK 0001441438 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,945 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.27 to $81.14, inclusive. The reporting person undertakes to provide to EXP World Holdings, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and ommission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| December 22, 2020 Filed Dec 24, 2020 02:11 UTC | AGNT, Inc. EXPI · Entity 5272 | Exercise / conversionCommon Stock | 20,000 | $10.64 | $212,800.00 |
DisclosureSEC source: 0001562180-20-007459 · primarydocument.xml · nonDerivative · entry 1 Bramble James · CIK 0001441438 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 20:14 UTC | AGNT, Inc. EXPI · Entity 5272 | GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $58.99 | $0.00 |
DisclosureSEC source: 0001562180-20-006347 · primarydocument.xml · derivative · entry 1 Bramble James · CIK 0001441438 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-10-09 F1 · derivative.exercise_date: This Stock Option vests in 16 equal quarterly installments beginning on October 9, 2020. Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 22:24 UTC | AGNT, Inc. EXPI · Entity 5272 | GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $10.64 | $0.00 |
DisclosureSEC source: 0001683168-19-000740 · ownership.xml · derivative · entry 1 Bramble James · CIK 0001441438 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2029-03-18 F1 · derivative.exercise_date: This Stock Option vests in 16 equal quarterly installments beginning on March 18, 2019. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 22:34 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | GrantRestricted Stock Units · Derivative | 5,580 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-001737 · edgar.xml · derivative · entry 1 Bramble James · CIK 0001441438 · Chief Legal Officer and Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,129 Underlying: Common Stock · 5,580 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 5th, 2018. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 5th, 2018. Read SEC document |
| October 23, 2017 Filed Oct 25, 2017 20:43 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | GrantRestricted Stock Units · Derivative | 2,549 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-013434 · edgar.xml · derivative · entry 1 Bramble James · CIK 0001441438 · Chief Legal Officer and Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,549 Underlying: Common Stock · 2,549 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of October 23rd, 2017. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of October 23rd, 2017. Read SEC document |
| August 21, 2017 Filed Aug 22, 2017 15:58 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionStock Settled Stock Appreciation Rights · Derivative | 37,000 | $0.00 Strike: $28.81 | $0.00 |
DisclosureSEC source: 0001179110-17-011721 · edgar.xml · derivative · entry 3 Bramble James · CIK 0001441438 · Chief Legal Officer and Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 37,000 shares Expires 2018-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 21, 2017 Filed Aug 22, 2017 15:58 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon stock | 18,298 | $57.01 | $1,043,254.98 |
DisclosureSEC source: 0001179110-17-011721 · edgar.xml · nonDerivative · entry 2 Bramble James · CIK 0001441438 · Chief Legal Officer and Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,076 F2 · price: Weighted average price $57.0147. Price range in multiple transactions was $57.00 to $57.30 inclusively. Read SEC document |
| August 21, 2017 Filed Aug 22, 2017 15:58 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionCommon Stock | 18,298 | $28.81 | $527,165.38 |
DisclosureSEC source: 0001179110-17-011721 · edgar.xml · nonDerivative · entry 1 Bramble James · CIK 0001441438 · Chief Legal Officer and Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,374 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares acquired resulted from the reporting person's settlement of the stock-setteld stock appreciation rights disclosed in Table-II Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.